Key facts
- Soar Autism Center’s last known valuation is $195.0M (Nov 2025).
- It has raised $55.0M; the latest was Later Stage VC ($17.0M) in Nov 2025.
- Notable investors include Brighton Health Partners, Cutting Horse, Divergent Investments, Standish Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Soar Autism Center
- ·The full record, as it builds
Funding rounds
No funding rounds for Soar Autism Center are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Soar Autism Center
Operator of a chain of autism care clinics intended to provide integrated therapy plus diagnostic services for young kids. The company's clinics offer naturalistic, developmentally appropriate applied behavior analysis, speech therapy, occupational therapy, and other mental health support services, enabling parents to utilize integrated care to treat their children.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2020
- Employees
- 602
- Website
- soarautismcenter.com/
- Ownership
- Privately Held (backing)
Soar Autism Center doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Soar Autism Center shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Soar Autism Center in its N-PORT filings yet. We sweep new filings monthly.